Muramyl dipeptide-based analogs as potential anticancer compounds: Strategies to improve selectivity, biocompatibility, and efficiency
According to the WHO, cancer is the second leading cause of death in the world. This is an important global problem and a major challenge for researchers who have been trying to find an effective anticancer therapy. A large number of newly discovered compounds do not exert selective cytotoxic activi...
Main Authors: | Eliza Iwicka, Justyna Hajtuch, Krystyna Dzierzbicka, Iwona Inkielewicz-Stepniak |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.970967/full |
Similar Items
-
The Role of the Bacterial Muramyl Dipeptide in the Regulation of GLP-1 and Glycemia
by: Laura Williams, et al.
Published: (2020-07-01) -
CLINICAL AND IMMUNOLOGICAL EFFICIENCY OF MURAMYL DIPEPTIDE IN THE TREATMENT OF ATOPIC DISEASES
by: N. V. Kolesnikova, et al.
Published: (2016-04-01) -
Effect of muramyl dipeptide and alum adjuvants on immunization with Filarial multi antigen peptide vaccine in mice model
by: Christiana I., et al.
Published: (2016-09-01) -
Effect of Lipopolysaccharide and Muramyl Dipeptide on Apoptosis of Bovine Mammary Gland Lymphocytes
by: Petr Slama, et al.
Published: (2020-06-01) -
Synthesis of New Lipophilic Phosphonate and Phosphonamidate Analogues of N-Acetylmuramyl-L-alanyl-D-isoglutamine Related to LK 423
by: Uroš Urleb, et al.
Published: (2002-05-01)